Japan Chemical Daily

Japan's leading chemical industry newspaper

Log In

PeptiDream to Set up CMO for Specialized Peptides

Filed Under: Innovation, Materials, Pharma Tagged With: , , , , , , , , , , , , , ,

PeptiDream Inc. (TYO:4587) is establishing Japan’s first contract manufacturing organization (CMO) for specialized peptides, which are attracting interest as post-peptide…...

Please subscribe to read the full story.

[lwa template="modal" register="0"] Register Free Trial

Related Articles:

Eisai Plans Entry Into Nucleic Acid Drug MarketEisai Plans Entry Into Nucleic Acid Drug Market
Chugai Pharmaceutical to Start Production in ChinaChugai Pharmaceutical to Start Production in China
Takeda Pharmaceutical to Form New Joint Venture With PRA in Japan, Restructure Clinical DevelopmentTakeda Pharmaceutical to Form New Joint Venture With…
Sumitomo Dainippon Pharma Targets GMP-Based Mass Production of Cellular MedicineSumitomo Dainippon Pharma Targets GMP-Based Mass…
Industry Outlook 2018: PharmaceuticalsIndustry Outlook 2018: Pharmaceuticals
Nippi to Increase Production of Collagen PeptidesNippi to Increase Production of Collagen Peptides

Send this to a friend